Inventiva SA

IVA

Company Profile

  • Business description

    Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

  • Contact

    50 rue de Dijon
    Daix21121
    FRA

    T: +33 380447500

    E: [email protected]

    https://www.inventivapharma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2025

    Employees

    118

Stocks News & Analysis

stocks

WiseTech result disappoints, but the future looks bright

Markets appear underwhelmed by recent sales growth, however, our kingmaker thesis is intact.
stocks

WOW earnings: Woolworths losing market share, but will catch up to Coles

Woolworths have had a soft start to a challenging year, but Morningstar analyst believes it will eventually catch up to its main competitor.
stocks

Chart of the Week: Largest share price falls during earnings

Opportunities arise when the market overreacts, and good quality companies are mispriced.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,225.0016.60-0.18%
CAC 407,743.9334.120.44%
DAX 4024,046.21106.66-0.44%
Dow JONES (US)45,565.23147.160.32%
FTSE 1009,255.5010.30-0.11%
HKSE25,201.76323.16-1.27%
NASDAQ21,590.1445.870.21%
Nikkei 22542,566.3846.110.11%
NZX 50 Index12,862.790.950.01%
S&P 5006,481.4015.460.24%
S&P/ASX 2008,960.809.70-0.11%
SSE Composite Index3,800.3568.03-1.76%

Market Movers